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ABSTRACT
BACKGROUND: IV epinephrine is widely used in the treatment of shock to in-
crease blood pressure (BP). However, whether it may also induce hypotension remains
unknown.
OBJECTIVE: The aim of this randomized, open-label, controlled pilot study was
to observe hemodynamic changes after an IV bolus of epinephrine in healthy rats.
METHODS: Healthy male Sprague-Dawley rats were randomized to 1 of5 groups
to receive IV epinephrine in doses of 0.5 pg/kg (group 1); 1 pg/kg (group 2); 2 pg/kg
(group 3); 4 pg/kg (group 4); or 8 pg/kg (group 5). A sixth group received placebo
(0.3 mL of normal saline) and served as the control. BP was monitored continuously.
Mean arterial pressure (MAP) and heart rate (HR) were recorded at 0, 5, 15, and
30 seconds and 1,2,3,4,6,8, 10, 12, 14, 16, 18, and 20 minutes after administra-
tion. The highest mean (SD) systolic BP (SBP) and the lowest mean (SD) diastolic BP
(DBP) during this period were also recorded. Hypertension and hypotension were
defined as BP increased or decreased> 10% from baseline.
RESULTS: Forty-two Sprague-Dawley rats were included in the study. The initial
hypertension occurred at -18 seconds in all epinephrine-treated groups (all, P <
0.01), and the subsequent hypotension occurred at mean (SD) 1.3 (0.5), 2.2 (0.4), 3.0
(0.6), and 3.4 (1.1) minutes in groups 2, 3,4, and 5, respectively (all, P < 0.01). The
highest mean (SD) SBP and the lowest mean (SD) DBP in groups 1,2, 3,4, 5, and
the control group were 184 (12)/78 (11), 208 (14)/78 (10), 219 (18)/69 (14), 232
(17)/55 (11), 243 (16)/56 (15), and 148 (12)/91 (7) mm Hg, respectively, compared
with baseline. HR decreased significantly at 15 seconds in groups 2 and 3, and at 5,
15, and 30 seconds in groups 4 and 5 (all, P < 0.01). One rat in group 4 and 1 rat in
group 5 died due to treatment-related cerebral hemorrhage. The control group had no
significant hemodynamic changes from baseline. Compared with the control group,
MAP increased significantly at 5,15, and 30 seconds and 1 minute in the epinephrine-
treated groups and decreased significantly at 2, 3, and 4 minutes in group 3 and at
2,3,4, and 6 minutes in groups 4 and 5 (all, P < 0.05).
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CONCLUSIONS: An IV bolus of epinephrine> 1 pg/kg was associated with bi-
phasic changes in BP, including initial hypertension and subsequent hypotension, in
these healthy rats. Future blinded and larger studies using lower doses are needed.
(Curr Ther Res Clin Exp. 2008;69:440-448) © 2008 Excerpta Medica Inc.
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INTRODUCTION
An IV bolus of epinephrine has been widely used in the treatment of patients in shock
to enhance heart contractility and increase blood pressure (BP).l-3 Different doses of
epinephrine may activate different types of sympathetic receptors. l In humans, epi-
nephrine administered at a rate of 1 to 2 pg/min predominantly activates ~2-receptors,
resulting in vascular and bronchial smooth muscle relaxation. l In contrast, epineph-
rine 2 to 10 pg/min predominantly activates ~l-receptors, resulting in increased heart
rate (HR), contractility, and conduction and a decreased refractory period. Doses
>10 pg/min were associated with marked a-stimulation, resulting in generalized
vasoconstriction. l Epinephrine may be administered intravenously as a bolus, and
usually a bolus dose for pressure support begins at 2 to 8 pg.l However, whether epi-
nephrine via IV bolus induces hypotension remains unknown.
Our previous studies and other published studies reported that local infiltration of
epinephrine might produce temporary hypotension during endoscopic sinus surgery4
and neurosurgery5-7 due to possible activation of ~2-receprorsduring general anes-
thesia. Two studies8,9 found that epinephrine administered endotracheally produced
hypotension with predominantly ~2-mediated effects in dogs. Significant hypoten-
sion may induce adverse effects1,5,7,lO,ll of the brain and heart, including stroke and
myocardial ischemia.
We hypothesized that an IV bolus of epinephrine may also cause hypotension. We
designed a prospective, randomized, open-label, controlled preliminary trial to ob-
serve hemodynamic changes after the administration of an IV bolus of epinephrine in
different doses in healthy rats.
MATERIALS AND METHODS
ANIMALS
The experimental protocol was reviewed and approved by the Institutional Animal
Care Committee of]inling Hospital, Nanjing, China. Healthy male Sprague-Dawley
rats weighing 250 to 300 g were purchased from the Institutional Animal Center of
]inling Hospital and were included in the study. The rats had been exposed to
12 hours of light and 12 hours of darkness daily. Rodent food and water were provided
ad libitum.
Using a randomized numeric table, the rats were divided into 6 groups of 7 and
received different doses of IV epinephrine diluted to a volume of 0.3 ml with nor-
mal saline. The following doses were administered: 0.5 pg/kg (group 1); 1 pg/kg
(group 2); 2 pg/kg (group 3); 4 pg/kg (group 4); or 8 pg/kg (group 5). The sixth
group received placebo (0.3 ml of normal saline) and served as the control. The doses
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of epinephrine selected in the present trial were determined according to the results
of our unpublished preliminary experiment, which were lower than the lethal dose
(LDso) (0.15 mg/kg) of IV epinephrine.
STUDY PROTOCOL
Anesthesia was induced using sodium pentobarbital 45 mg/kg intraperitone-
ally. Within 30 minutes, the left femoral artery and the right femoral vein were
cannulated to measure BP and to inject epinephrine or normal saline. A supple-
mental dose of sodium pentobarbital 20 mg/kg was administered intraperitone-
ally to maintain anesthesia. After 10 minutes, when a steady depth of anesthesia
was achieved, epinephrine (in groups 1-5) or normal saline (in control group) was
injected intravenously within 3 seconds. Thereafter, lactated Ringer's solution
10 mLikg/h was infused intravenously to supplement the physiologic need lost
via urination, evaporation, and perspiration. BP was monitored continuously. The
highest mean (SD) systolic BP (SBP) and the lowest mean (SD) diastolic BP
(DBP) during this period were also recorded. Hypertension and hypotension were
defined as BP increased or decreased> 10% from baseline. Mean arterial pressure
(MAP) and HR were recorded at 0,5, 15, and 30 seconds and at 1,2,3,4,6,8,
10, 12, 14, 16, 18, and 20 minutes in all rats after administration of an IV bolus
of epinephrine or normal saline.
STATISTICAL ANALYSIS
Because this was a preliminary study, a power analysis was not performed, nor was
a primary end point selected. Statistical analysis was performed using the SPSS version
13.0 (SPSS Inc., Chicago, Illinois). Ordinal data are expressed as a percentage or a
proportion, and quantitative data as mean (SD).
Sequential measurements of MAP and HR were analyzed using analysis of
variance (ANOVA) for repeated measurements, followed by pairwise comparisons.
Baseline hemodynamics were analyzed using I-way ANOVA followed by least
significant difference (LSD) tests for post hoc multiple comparisons; intragroup
comparisons were made using I-way ANOVA followed by LSD tests (equal vari-
ances) or Dunnett's T3 tests (unequal variances) for post hoc multiple compari-
sons. Intergroup comparisons were made using analysis of covariance (dependent
variable, hemodynamic value; fixed factor, group; covariate, baseline hemodynam-
ics). The highest mean (SD) SBP and the lowest mean (SD) DBP were compared
with baseline values using paired t tests. P < 0.05 was considered statistically
significant.
RESULTS
ANIMALS
Forty-two rats were included in the study. Of this number, 40 completed the study
protocol. One rat in group 4 and 1 rat in group 5 died due to treatment-related
cerebral hemorrhage. Their data recorded before the hemorrhage occurred were also
analyzed according to the intent-to-treat method.
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HEMODYNAMIC CHANGES
The epinephrine-treated groups experienced significant hemodynamic changes com-
pared with the control group. BP increased initially and significantly in the epinephrine-
treated groups. Compared with baseline, hypertension was observed after administra-
tion of the IV bolus of epinephrine only in group 1 (at 5, 15, and 30 seconds, P < 0.01;
and at 1 minute, P < 0.05). However, biphasic BP changes including the initial hy-
pertension and the subsequent hypotension were observed in groups 2, 3,4, and 5 (all,
P < 0.01) (Table).
Compared with baseline, MAP was increased significantly at 5, 15, and 30 sec-
onds and 1 minute in all 5 epinephrine-treated groups. However, MAP was de-
creased significantly at 2, 3, and 4 minutes at the higher doses of epinephrine
(groups 3,4, and 5); this decrease was maintained at 6 minutes in groups 4 and 5
(all, P ~ 0.05). MAP was not significantly decreased at the lower doses of epineph-
rine (groups 1 and 2). No significant hemodynamic changes were found in the
control group (Figure 1).
Compared with baseline, the highest mean (SD) SBP and the lowest mean (SD)
DBP in groups 1,2,3,4,5, and the control were 184 (12)/78 (11), 208 (14)/78 (0),
219 (18)/69 (14),232 (17)/55 (11), 243 (16)/56 (15), and 148 (12)/91 (7) mm Hg,
respectively. The percentage increases of the highest mean (SO) SBPs ([the highest
mean SBP/baseline mean SBP - I} . 100%), which occurred at -18 sec, was as fol-
lows: 43.3%, 50.7%, 56.3%,82.7%, and 84.1 % in groups 1,2,3,4, and 5, respec-
tively. The percentage decreases of the lowest mean DBPs ([1 - the lowest mean
DBP/baseline mean DBP} . 100%), which occurred at 1.3 (0.5), 2.2 (0.4), 3.0 (0.6),
and 3.4 (1.1) minutes in groups 2, 3,4, and 5, respectively, were 17.0%,27.8%,
36.0%, and 40.0% (Table).
Compared with baseline, HR was decreased significantly at 15 seconds in groups
2 and 3 and at 5, 15, and 30 seconds in groups 4 and 5 (all, P < 0.01). There was
Table. Baseline and highest systolic blood pressure (SBP) and baseline and lowest dia-
stolic blood pressure (OBP) (N =42). Data are mean (SO) mm Hg.
SBP DBP
No. of
Group Rats Baseline Highest p* Baseline Lowest p*
1 7 128 (5) 184 (12) <0.001 82 (10) 78 (11) 0.067
2 7 138 (17) 208 (14) <0.001 94 (7) 78 (10) 0.001
3 7 140 (12) 219 (18) <0.001 95 (8) 69 (14) 0.001
4 7 127 (12) 232 (17) <0.001 86 (14) 55 (11) 0.001
5 7 132 (12) 243 (16) <0.001 94 (10) 56 (15) 0.001
6 (control) 7 144 (13) 148 (12) 0.521 95 (7) 91 (7) 0.282
IV epinephrine doses: 0.5 ~gjkg (group 1); 1 IJgjkg (group 2): 2 IJgjkg (group 3); 4 IJgjkg (group 4);
and 8 ~gjkg (group 5).
*Versus baseline.
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Figure 1. Mean (SD) mean arterial pressure (MAP) after an IV bolus of epinephrine or saline (control). Significant findings: groups
1 and 2: P < 0.01 at 5, 15, and 30 seconds and P < 0.05 at 1 minute; group 3: P < 0.01 at 5, 15, and
30 seconds and 2 and 3 minutes and P < 0.05 at 1 and 4 minutes; groups 4 and 5: P < 0.01 at 5, 15, and 30 seconds
and 1, 2, 3, 4, and 6 minutes. No significant hemodynamic changes were found in the control group (6).
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no significant change in the control group. Compared with the control group, HR
was decreased significantly at 15 seconds in groups 2 and 3 and at 5, 15, and 30 sec-
onds in groups 4 and 5 (all, P < 0.01). There was no significant change in group 1
(Figure 2).
DISCUSSION
The present trial used a healthy animal model to evaluate the hemodynamic effects of an
IV bolus of epinephrine and found that only epinephrine 0.5 Jlg/kg was associated with
hypertension, while relatively larger doses (1-8 Jlg/kg) were associated with a marked in-
crease and then a pronounced decrease in BP and was also associated with death.
BP reached its highest point at -18 seconds in all of the epinephrine-treated
groups, indicating that different doses of epinephrine were associated with hyperten-
sion at the same time. Homma et al lZ found that during dental treatment in humans,
the mean plasma epinephrine Cmax was reached 3 minutes after local infiltration of
lidocaine containing different doses of epinephrine. John et al 13 found that during
endoscopic sinus surgery, plasma epinephrine concentration increased markedly
within 4 minutes of the start of drug infiltration on nasal mucosa in humans. The
increase was not related to the total amount of epinephrine administered.
The increase in BP was probably due to the effect on a- and Bl-adrenergic recep-
rors. It is expected that the larger the dose of epinephrine, the greater the increase in
BP. Although the LDso of IV epinephrine in rats, 0.15 mg/kg,14 is much greater than
the doses used in the present trial, 2 rats did die (in groups 4 and 5). These rats expe-
rienced severe end-organ damage including cerebral hemorrhage as a result of the
hypertension induced by epinephrine infusion.
Because of the association with the elimination of epinephrine, the activation of
a-receptors decreased and that of Bz-receptors increased; vasodilatation occurred
thereafter. Hypotension was observed after the initial hypertension occurred in groups
2, 3,4, and 5. Linton and Linton lS found that epinephrine 5 Jlg IV administered to
patients before and after cardiopulmonary bypass surgery caused an initial increase in
MAP that was followed within 20 seconds by a decrease to a level below baseline. In
the present study, no hypotension was observed in group 1, perhaps because physio-
logic homeostasis compensated for the small dose of epinephrine.
Hypotension might result in lower organ perfusion, perhaps even resulting in heart
failure. In the present study, severe hypotension occurred when using larger doses of
epinephrine, perhaps because excessively high BP may have led to cardiac ischemia
and might have aggravated hypotension.
In groups 2, 3,4, and 5, when BP increased, the decrease in HR was most likely
due to the effect of the baroreceptor reflex on HR being stronger than that of the
activation of ~l-receptors.
LIMITATIONS
There were some limitations in interpreting the results of the present study. A
major limitation was that 1 rat died in both groups 4 and 5, suggesting that the doses
of epinephrine were too high in those groups. We did not measure the plasma concen-
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Figure 2. Mean (SO) changes in heart rate (HR) after an IV bolus of epinephrine. Compared with baseline, HR decreased signifi-
cantly at 15 seconds In groups 2 and 3 and at 5, 15, and 30 seconds in groups 4 and 5 (all, P < 0.01). There was no
significant change in the control group.
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trations of epinephrine after the IV bolus when significant BP changes occurred. In
addition, the small sample size and the fact that the researchers were not blinded may
have been threats to the validity of the results of this study.
CONCLUSIONS
An IV bolus of epinephrine > 1 I.lg/kg was associated with biphasic changes in BP,
including initial hypertension and subsequent hypotension, in these healthy rats.
Future blinded and larger studies using lower doses are needed.
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